The abstract is read at the publisher; the summary is JClub's.
MDM2 promotes K48-linked polyubiquitination of MEIS1 at K178, driving MEIS1 proteasomal degradation and enabling p53 activation in the DNA damage response.
- Why it matters: Therapeutic strategies that target MDM2 must restore p53 while avoiding toxicity, yet MDM2 also ubiquitinates non-p53 substrates that complicate selective control.
- What they did: The study shows MDM2 directly ubiquitinates MEIS1 at K178 and that MEIS1 forms a non-competitive ternary complex with MDM2 and p53, while a MEIS1 K178R mutant cannot suppress MDM2-mediated p53 ubiquitination.
- The result: MDM2-dependent MEIS1 ubiquitination is required for p53 activation after DNA damage, and a MEIS1-derived peptide that mimics the ubiquitination motif increases MEIS1 and p53 stability while suppressing proliferation and tumor growth.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.